Cwm LLC Has $3.58 Million Holdings in Colgate-Palmolive Company $CL

Cwm LLC grew its position in shares of Colgate-Palmolive Company (NYSE:CL) by 20.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 45,345 shares of the company’s stock after purchasing an additional 7,665 shares during the quarter. Cwm LLC’s holdings in Colgate-Palmolive were worth $3,583,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Pacer Advisors Inc. raised its stake in Colgate-Palmolive by 3,052.2% during the third quarter. Pacer Advisors Inc. now owns 2,697,047 shares of the company’s stock worth $215,602,000 after buying an additional 2,611,485 shares during the last quarter. Diamond Hill Capital Management Inc. lifted its holdings in Colgate-Palmolive by 46.7% in the third quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock valued at $645,719,000 after buying an additional 2,572,796 shares during the period. Amundi boosted its position in Colgate-Palmolive by 41.6% during the third quarter. Amundi now owns 6,294,445 shares of the company’s stock valued at $487,505,000 after acquiring an additional 1,850,412 shares during the last quarter. Two Sigma Investments LP grew its holdings in Colgate-Palmolive by 360.9% during the 3rd quarter. Two Sigma Investments LP now owns 2,126,249 shares of the company’s stock worth $169,972,000 after acquiring an additional 1,664,949 shares during the period. Finally, SG Americas Securities LLC grew its holdings in Colgate-Palmolive by 3,896.0% during the 4th quarter. SG Americas Securities LLC now owns 1,189,005 shares of the company’s stock worth $93,955,000 after acquiring an additional 1,159,250 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on CL shares. Piper Sandler dropped their price objective on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 8th. Morgan Stanley raised their price objective on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a research report on Monday, February 2nd. Deutsche Bank Aktiengesellschaft upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and lifted their price objective for the company from $90.00 to $98.00 in a research note on Monday, March 30th. JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $97.00 to $95.00 and set an “overweight” rating on the stock in a research note on Friday, April 17th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. Twelve analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $95.88.

Insider Buying and Selling at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 97,843 shares of Colgate-Palmolive stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the completion of the transaction, the chief financial officer directly owned 55,310 shares in the company, valued at $5,214,073.70. This trade represents a 63.89% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John Hazlin sold 20,989 shares of the business’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the sale, the insider directly owned 17,645 shares of the company’s stock, valued at approximately $1,663,041.25. The trade was a 54.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 184,683 shares of company stock valued at $17,486,693 over the last ninety days. 0.43% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Trading Up 0.5%

Shares of Colgate-Palmolive stock opened at $82.25 on Thursday. The stock has a market capitalization of $65.99 billion, a PE ratio of 31.39, a price-to-earnings-growth ratio of 4.17 and a beta of 0.34. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33. The stock has a 50 day moving average price of $89.27 and a two-hundred day moving average price of $83.82. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. During the same period in the prior year, the firm earned $0.91 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 5.8% on a year-over-year basis. As a group, equities analysts anticipate that Colgate-Palmolive Company will post 3.87 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be issued a dividend of $0.53 per share. The ex-dividend date is Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 annualized dividend and a yield of 2.6%. Colgate-Palmolive’s dividend payout ratio is currently 80.92%.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.